Benzinga's Top Pre-Market NASDAQ Losers (AMSC, OPTR, CIEN, GOLD)

American Superconductor Corporation AMSC dipped 43.33% to $14.10 in the pre-market session. AMSC projects a loss and lower revenue for its fiscal fourth quarter and forecast lower-than-expected earnings for the full year. Optimer Pharmaceuticals Inc OPTR lost 2.17% to $13.50 in the pre-market session. The Food and Drug Administration (FDA) panel recommended approval for OPTR's antibiotic Dificid. Ciena Corporation CIEN moved down 1.09% to $26.26 in the pre-market session. CIEN's PEG ratio is 20.82. Randgold Resources Limited GOLD fell 1.00% to $86.96 in the pre-market trading. Randgold's trailing-twelve-month ROE is 6.84%. Read more from Benzinga's Markets.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDAPre-Market OutlookIntraday UpdateMarketsCommunications EquipmentElectrical Components & EquipmentGoldHealth CareIndustrialsInformation TechnologyMaterialsPharmaceuticalsTop Pre-Market NASDAQ Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!